Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2014-02-28
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis
NCT00867607
To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function
NCT03804710
Xerosis and Use of Topical Moisturizer
NCT04341623
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
NCT02576938
Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier Function
NCT04097327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bariederm, barrier cream
one arm study: use of bariederm cream on hands twice daily for 21 days
bariederm cream
patients are asked to apply twice a day a barrier cream on their hands for 3 weeks only
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bariederm cream
patients are asked to apply twice a day a barrier cream on their hands for 3 weeks only
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* known allergy to ingredients -
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hadassah Medical Organization
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
rliranoHMO
DR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liran Horev Yakir, MD
Role: PRINCIPAL_INVESTIGATOR
Dept of Dermatology, Hadassah Medical Center, Jerusalem 911201, Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
: Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
bariederm-HMO-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.